Nexsen Limited (ASX:NXN)
Australia · Delayed Price · Currency is AUD 0.1850
+0.0050 (2.78%)
Last updated: Sep 11, 2026, 11:41 AM AEST
Nexsen Market Cap
Nexsen has a market cap or net worth of 36.04 million as of September 10, 2026.
Market Cap
36.04M
Enterprise Value
31.56M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
ChartMarket Cap Chart
Since October 14, 2025, Nexsen's market cap has decreased from 56.05M to 36.04M, a decrease of -35.71%. That is a compound annual growth rate of -38.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 36.04M | 12.50% |
| Dec 31, 2025 | 32.03M | -42.86% |
| Oct 14, 2025 | 56.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 66.73M |
| Neurizon Therapeutics | 65.88M |
| Botanix Pharmaceuticals | 54.73M |
| Radiopharm Theranostics | 39.04M |
| Imugene | 30.85M |
| Proteomics International Laboratories | 23.98M |
| EZZ Life Science Holdings | 23.77M |
| NeuroScientific Biopharmaceuticals | 23.38M |